临床与病理杂志2018，Vol.38Issue(1)：198-204,7.DOI:10.3978/j.issn.2095-6959.2018.01.033
富亮氨酸胶质瘤失活1蛋白抗体相关脑炎的研究进展
Research progress in leucine-rich glioma inactivated I protein antibody-associated encephalitis
李维帅1
作者信息
- 1. 中国医科大学附属盛京医院神经内科,沈阳 110000
- 折叠
摘要
Abstract
Leucine-rich glioma inactivated 1 (LGil) protein antibody-associated encephalitis is a new type of autoimmune encephalitis, characterized by cognitive impairment and epilepsy and faciobrachial dystonic seizures (FBDS) and intractable hyponatremia. Unlike traditional adenomatous autoimmune encephalitis, it is usually not tumourassociated, and its prognosis is better after immunomodulatory therapy.关键词
富亮氨酸胶质瘤失活1蛋白/面臂肌张力障碍发作/顽固性低钠/治疗/预后Key words
leucine-rich glioma inactivated 1 protein/faciobrachial dystonic seizures/intractable hyponatremia/treatment/prognosis引用本文复制引用
李维帅..富亮氨酸胶质瘤失活1蛋白抗体相关脑炎的研究进展[J].临床与病理杂志,2018,38(1):198-204,7.
